Bill Snyder

February 2, 2017

New Physician Science Doctoral Program graduates first student

As a fellow in pulmonary and critical care medicine at Vanderbilt University School of Medicine, Bradley Richmond, M.D., saw a lot of patients with chronic obstructive pulmonary disease (COPD), an inflammatory lung disease caused most often by long-term exposure to cigarette smoke.

By Bill Snyder
January 26, 2017

New management software bolsters research cores

This month the Office of Research at Vanderbilt University Medical Center (VUMC) began transitioning VUMC research cores, facilities and shared resources (known collectively as “cores”) to a new core management application that officials said will streamline ordering and billing for core services.

By Bill Snyder
January 26, 2017

Global health meet explores future needs

The health of people around the world depends to a large extent on the ability of the global health community to predict what challenges must be met in the future.

By Bill Snyder
January 24, 2017

Casagrande recalled as neuroscience pillar, supportive mentor

Vivien Casagrande, Ph.D., a neuroscientist and professor at Vanderbilt University School of Medicine (VUSM) noted for her many contributions to the visual sciences, died peacefully at her home on Saturday, Jan. 21. She was 74.

By Bill Snyder
January 24, 2017

Saliva test for obesity risk

“Epigenetic signatures” in DNA may present an opportunity for prevention of or early intervention in childhood obesity.

By Bill Snyder
Close-up of a woolen knitted texture (blue)
January 19, 2017

Surprising finding by VU team sheds light on fibrotic disease

Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings.

By Bill Snyder
January 19, 2017

COX-2 ‘conjugate’ may slow growth of some tumors: study

More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.
By Bill Snyder
January 19, 2017

GRE may be poor predictor of science success: study

Since it was created in 1949, the Graduate Record Exam (GRE) has been one of the most widely used requirements for admission to U.S. graduate schools. As a predictor of performance and success in graduate school, however, the exam is not without its critics.
By Bill Snyder
January 19, 2017

Amount of daylight may impact serotonin programming

The duration of exposure to daylight, or the “photoperiod,” may affect development of seasonal affective disorder by programming serotonin neurons in the brain, according to Vanderbilt University researchers.
By Bill Snyder
January 17, 2017

A heart-brain connection

Cognitive and attention deficits observed in children following surgery before age 5 to repair congenital heart defects likely will persist into their teens and young adulthood.
By Bill Snyder
January 12, 2017

Lindsley’s drug discovery efforts land ASPET Award

Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
By Bill Snyder
January 12, 2017

Team’s discovery offers new insight on lung cancer risk

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.
By Bill Snyder
1 … 64 65 66 67 68 … 110